Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: FF;   Drug: UMEC;   Drug: VI
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified May 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days